[3P-0339] Invention of compounds with specific growth inhibitory activity against T-cell acute lymphoblastic leukemia-derived cells

○Yuki Fujita^1,2, Tomoya Higashi^1,2, Yoshihumi Hachiro^1,2, Chihiro Yoshida^1,2, Chihiro Nakata^3,4, Takuya Yagi^3,4, Azusa Takechi^3,5, Nobuo Kitada^1,2, Rika Obata^1,2, Takahiko Hara^3,4,5, Shojiro Maki^1,2 (1. Dept. of Info. Sci., Grad. Sch., Univ. of Electro-Communications, 2. Center for Neuro Sci. and BioMed. Eng., Univ. of Electro-Communications, 3.Stem Cell Project., Tokyo Metropolitan Institute of Medical Science, 4.Dept. of Med. and Dent., Univ. of Tokyo Medical and Dental, 5.Dept. of Stem Cell reg., Univ. of Tokyo Metropolitan)

Leukemia, cancer, drug, structure-activity relationship